SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study

R Laxminarayan, TG Vinay, KVA Kumar… - The Lancet Infectious …, 2021 - thelancet.com
Background SARS-CoV-2 has spread substantially within India over multiple waves of the
ongoing COVID-19 pandemic. However, the risk factors and disease burden associated with …

Prevalence of SARS-CoV-2 infection in India: Findings from the national serosurvey, May-June 2020

MV Murhekar, T Bhatnagar, S Selvaraju… - Indian Journal of …, 2020 - journals.lww.com
Methods: From May 11 to June 4, 2020, a randomly sampled, community-based survey was
conducted in 700 villages/wards, selected from the 70 districts of the 21 States of India …

SARS-CoV-2 seroprevalence in 12 cities of India from July-December 2020

A Velumani, C Nikam, W Suraweera, SH Fu… - medRxiv, 2021 - medrxiv.org
Objectives We sought to understand the spread of SARS-CoV-2 infection in urban India,
which has surprisingly low COVID-19 deaths. Design Cross-sectional and trend analyses of …

The seroprevalence and trends of SARS-CoV-2 in Delhi, India: A repeated population-based seroepidemiological study

N Sharma, P Sharma, S Basu, S Saxena, R Chawla… - MedRxiv, 2020 - medrxiv.org
Background Three rounds of a repeated cross-sectional serosurvey to estimate the
seroprevalence and trends of SARS-CoV-2 were conducted from August-October'2020 in …

SARS-CoV-2 Seroprevalence in Tamil Nadu in October-November 2020

A Malani, S Ramachandran, V Tandel, R Parasa… - MedRxiv, 2021 - medrxiv.org
A population-representative serological study was conducted in all districts of the state of
Tamil Nadu (population 72 million), India, in October-November 2020. State-level …

[HTML][HTML] Population point prevalence of SARS-CoV-2 infection based on a statewide random sample—Indiana, April 25–29, 2020

N Menachemi - MMWR. Morbidity and mortality weekly report, 2020 - cdc.gov
Population Point Prevalence of SARS-CoV-2 Infection Based on a Statewide Random
Sample — Indiana, April 25–29, 2020 | MMWR Skip directly to site content Skip directly to …

Epidemiology of COVID-19 and effect of public health interventions, Chennai, India, March–October 2020: an analysis of COVID-19 surveillance system

M Jagadeesan, P Ganeshkumar, P Kaur… - BMJ open, 2022 - bmjopen.bmj.com
Objectives To describe the public health strategies and their effect in controlling the COVID-
19 pandemic from March to October 2020 in Chennai, India. Setting Chennai, a densely …

[HTML][HTML] SARS-CoV-2 Seroprevalence in Delhi, India, during September-October 2021: a population-based seroepidemiological study

P Sharma, S Basu, S Mishra, E Gupta, R Agarwal… - Cureus, 2022 - ncbi.nlm.nih.gov
Background A previous community-based severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) serosurvey in Delhi in January 2021 reported a seroprevalence of 50.52 …

Seroprevalence of SARS-CoV-2 in Bhubaneswar, India: findings from three rounds of community surveys

JS Kshatri, D Bhattacharya, I Praharaj… - Epidemiology & …, 2021 - cambridge.org
The study aims to estimate and compare the severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) seroprevalence, the fraction of asymptomatic or subclinical infections in the …

All-cause mortality during the COVID-19 pandemic in Chennai, India: an observational study

JA Lewnard, A Mahmud, T Narayan, B Wahl… - The Lancet Infectious …, 2022 - thelancet.com
Background India has been severely affected by the ongoing COVID-19 pandemic.
However, due to shortcomings in disease surveillance, the burden of mortality associated …